Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 30, 2025, Phio Pharmaceuticals (PHIO) has a market cap of $9.461 million USD. According to our data, Phio Pharmaceuticals is ranked No.8837 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 30, 2025 | $9.46 M |
10.03%
|
| Dec 31, 2024 | $8.60 M |
-73.68%
|
| Dec 29, 2023 | $32.67 M |
-82.97%
|
| Dec 30, 2022 | $0.19 B |
-62.80%
|
| Dec 31, 2021 | $0.52 B |
-62.83%
|
| Dec 31, 2020 | $1.39 B |
-71.40%
|
| Dec 31, 2019 | $4.85 B |
-48.18%
|
| Dec 31, 2018 | $9.36 B |
-94.06%
|
| Dec 29, 2017 | $157.76 B |
-22.24%
|
| Dec 30, 2016 | $202.88 B |
-81.28%
|
| Dec 31, 2015 | $1.084 T |
-76.13%
|
| Dec 31, 2014 | $4.540 T |
-44.83%
|
| Dec 31, 2013 | $8.229 T |
28.89%
|
| Dec 31, 2012 | $6.384 T |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Arrowhead Pharmaceuticals
ARWR
|
$1.85 B |
-0.000 M
|
USA
|
 Alnylam Pharmaceuticals
ALNY
|
$33.29 B |
-0.001 M
|
USA
|
 Ionis Pharmaceuticals
IONS
|
$4.74 B |
0.000 M
|
USA
|
 Sarepta Therapeutics
SRPT
|
$5.98 B |
0.000 M
|
USA
|
 Moderna
MRNA
|
$10.76 B |
0.000 M
|
USA
|
 BioNTech
BNTX
|
$25.00 B |
0.001 M
|
Germany
|
 Regeneron Pharmaceuticals
REGN
|
$62.20 B |
1.034 B
|
USA
|
 Intellia Therapeutics
NTLA
|
$0.85 B |
-0.000 M
|
USA
|
 Editas Medicine
EDIT
|
$0.13 B |
0.000 M
|
USA
|
 CRISPR Therapeutics
CRSP
|
$3.23 B |
-0.000 M
|
Switzerland
|
 Beam Therapeutics
BEAM
|
$1.98 B |
-0.000 M
|
USA
|
 Sangamo Therapeutics
SGMO
|
$0.16 B |
0.000 M
|
USA
|
 bluebird bio
BLUE
|
$40.34 M |
0.000 M
|
USA
|
| Market Cap | = | PHIO Stock Price | * | PHIO Shares Outstanding |
| = | $1.98 | * | 4.78 M | |
| = | $9.46 M |